Correction: Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain
This correction announces that the review of relugolix/estradiol/norethisterone acetate for endometriosis-associated pain has been made open access, funded by Sumitomo Pharma and Pfizer.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This document is a formal correction notice published in the journal Drugs, addressing the original review article titled "Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain" by Hannah A. Blair. The primary change involves updating the publication status from closed access to Open Access, funded by Sumitomo Pharma Switzerland GmbH and Pfizer, while retaining the original content and license terms. No scientific findings or clinical data are presented within this specific text, as it serves solely to amend copyright and accessibility metadata for the previously published work. This paper is centrally about endometriosis — specifically serving as the administrative correction record for a drug review focused on treating pain associated with that condition.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
2,909 characters
· extracted from
oa-pdf
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-10-05T06:18:27.067365+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-05T06:16:08.524559+00:00